Ask My Investor AI
Public company · NYSEPublished company research
AME

Seed ticker hint 'AME' validated as correct and exchange confirmed as NYSE (not Nasdaq). Identity corroborated by the packet's SEC-verified prior_batch (CIK 0001037868, EDGAR registrant string 'AMETEK INC/', NYSE:AME, USD, FY ends Dec 31) and independently by AMETEK's FY2025 results press release and corporate About page (HQ Berwyn, Pennsylvania). Direct SEC EDGAR fetch returned HTTP 403, so the SEC-derived legal name/CIK is reused from the packet's prior verification rather than re-extracted; legal_name shown as 'AMETEK, Inc.' (EDGAR lists the registrant as 'AMETEK INC/').

AMETEK, Inc.

AMETEK is a diversified, high-margin precision-instruments and electromechanical manufacturer that posted record FY2025 results: net sales of $7.4 billion (up 7% vs 2024), GAAP operating income of $1.91 billion, a 26.2% adjusted operating margin, diluted EPS of $6.40 and free cash flow of roughly $1.67 billion. Its disciplined acquisition engine (FARO Technologies and Kern Microtechnik in 2025) compounds capital into structural-growth niches, including metrology and industrial inspection, semiconductor analysis, aerospace and medical. The evidence supports a durable-compounder profile; the analytical limits are the absence of a separately disclosed metrology/inspection revenue line and the lack of licensed market data to assess valuation.

Ask follow-up research
Reviewed company research · researched 2026-07-22 · not an individual investment recommendation
Listing
public
Ticker
AME
Exchange
NYSE
HQ
United States
Currency
USD
SEC CIK
0001037868
Investment case

How this company captures the theme economics

Competitive position

AMETEK holds category-leading positions in narrow, mission-critical precision instrument and electromechanical niches rather than broad commodity markets. It operates two reportable groups (EIG ~66% of sales, EMG ~34%) and sustains ~26% operating margins with high cash conversion, evidence of pricing power, differentiated engineering and a broad installed base. Its scale in metrology, analytical instrumentation and motion control, plus a serial bolt-on M&A model (the AMETEK Growth Model), reinforce a wide, fragmented-market moat.

Scarce assets

A portfolio of category-defining measurement and inspection brands within the Ultra Precision Technologies Division and broader EIG: FARO (laser trackers, portable measurement arms, optical CMMs, scan-to-CAD inspection software), Creaform and Virtek (3D scanning/laser projection), Zygo (optical metrology), Taylor Hobson (nanometric surface metrology), Precitech, plus analytical-inspection franchises Gatan (TEM imaging), CAMECA (SIMS/atom-probe tomography) and SPECTRO/Nu Instruments. These embed nanometric-accuracy measurement IP, a large installed base with aftermarket pull-through, and a proven capital-allocation track record.

Products, segments, and customers

Two operating groups. Electronic Instruments Group (EIG; FY2025 sales $4,919M, operating income $1,447M) makes advanced instruments for process, power & industrial, and aerospace markets, and houses the Ultra Precision Technologies metrology/inspection franchise and semiconductor analytical instruments. Electromechanical Group (EMG; FY2025 sales $2,482M, operating income $578.9M) supplies precision motion control, engineered medical components, thermal management, specialty metals and electrical interconnects into aerospace & defense, medical, automation and other industrial end markets. Operations span North America, Europe, Asia and South America.

Theme capture

AMETEK captures industrial-inspection economics by selling the measurement, metrology and inspection hardware and software that quality-control and reindustrialization workflows depend on: laser trackers, measurement arms, optical CMMs, 3D scanners, surface/optical metrology and scan-to-CAD inspection software, plus analytical/inspection instruments for semiconductor and materials work. The July 2025 completion of the FARO acquisition (~$920M net of cash; FARO ~$340M annual sales) materially deepened its 3D-metrology and digital-inspection leadership. Demand is driven by reshoring/reindustrialization capex, semiconductor and AI/data-center buildout, and aerospace and EV/battery quality-control requirements. The equipment plus recurring software/service and aftermarket revenue convert this inspection bottleneck into high-margin, sticky sales.

Conditions

What must be true

  1. Reindustrialization/reshoring, semiconductor and aerospace capex must sustain demand for high-precision inspection and metrology equipment so that EIG structural-growth end markets keep growing faster than the cyclical industrial baseline.
  2. AMETEK must integrate FARO and other acquisitions accretively while sustaining ~26% operating margins and free-cash-flow conversion near or above 100% of net income.
  3. The acquired metrology/inspection franchise (Ultra Precision Technologies) must keep gaining share and pricing in nanometric-accuracy and 3D-measurement niches rather than being commoditized.

Identifiable catalysts

  • Realization of FARO integration and cross-selling synergies following the July 2025 close.
  • Entry into 2026 with a record backlog cited by management in the FY2025 results release.
  • Continued accretive bolt-on M&A (e.g., Kern Microtechnik) funded by strong free cash flow and low leverage (interest coverage ~23.5x).
  • Cyclical recovery in semiconductor, aerospace and automation quality-control spend.
Theme materiality

1 mapped theme

Exposure statements are evidence-qualified. Materiality is only claimed where disclosure supports it.

Test-and-measurement / metrology and inspection equipment and software provider — supplies the precision measurement, 3D scanning, surface/optical metrology and analytical-inspection instruments that gate industrial quality control and reindustrialization workflows.

Industrial inspection as the hidden reindustrialization bottleneck

High and disclosed at the product-line/brand level. AMETEK's EIG houses a deep test-and-measurement and inspection franchise (Ultra Precision Technologies Division: FARO, Creaform, Virtek, Zygo, Taylor Hobson, Precitech) plus semiconductor analytical-inspection brands (Gatan, CAMECA, SPECTRO/Nu Instruments). The July 2025 FARO acquisition (~$920M; ~$340M sales) explicitly targets 3D metrology, laser projection and digital-inspection leadership. Exposure is real and issuer-named, but its precise magnitude is not quantified because AMETEK reports only two segments and does not break out metrology/inspection revenue.

Evidence
Supported by the issuer's FARO acquisition disclosure (metrology, laser trackers, optical CMMs, scan-to-CAD inspection software joining the Ultra Precision Technologies Division within EIG) and AMETEK's own semiconductor-innovation materials naming Taylor Hobson (nanometric surface metrology), Gatan (TEM imaging) and CAMECA (SIMS/atom-probe inspection). Limiting factor: only EIG-level financials are disclosed (FY2025 EIG sales $4,919M), so inspection/metrology revenue cannot be isolated from public segment data.
Materiality
disclosed — The issuer names the specific metrology/inspection product lines, brands and the FARO acquisition that constitute the exposure, so the linkage itself is disclosed. However, the dollar magnitude within the theme is not separately quantified — AMETEK's smallest reportable granularity is the EIG segment, which also contains non-inspection process, power and aerospace instruments.
Financial evidence

Official SEC filing evidence

Reference period: FY2025.

  • Total net sales$7.4 billion, up 7% vs FY2024 (EIG $4,919M + EMG $2,482M)
    FY2025[2]
  • GAAP operating income$1,910.3 million
    FY2025[1]
  • Adjusted operating margin (non-GAAP)26.2% (adjusted operating income $1.94 billion, up 7%)
    FY2025[2]
  • EIG segment sales / operating incomesales $4,919M; operating income $1,447M
    FY2025[2]
  • EMG segment sales / operating incomesales $2,482M; operating income $578.9M
    FY2025[2]
  • GAAP diluted EPS$6.40
    FY2025[1]
  • Operating cash flow$1,801.8 million
    FY2025[1]
  • Free cash flow (derived: OCF less capex)$1,671.5 million
    FY2025[1]
  • Capital expenditures$130.2 million
    FY2025[1]
  • Cash and cash equivalents$458.0 million
    FY2025 year-end[1]
  • Interest coverage (derived)23.5x
    FY2025[1]
  • Diluted share count231.3 million shares
    FY2025[1]

Limitation: Valuation cannot be assessed: enterprise_value_to_ebitda and free_cash_flow_yield had no market observation in the packet and no licensed market-data feed was available. In the packet's metric set, revenue, gross profit, net income, EBITDA and total/net debt were flagged unavailable; total net sales ($7.4B) and EIG/EMG segment sales are therefore sourced from the issuer's FY2025 results press release rather than the packet's 10-K metric extraction. Full-year operating and free cash flow are the packet's reported/derived 10-K figures (the press release itemized only the fourth-quarter cash-flow amounts).

Risks

Material risks and break conditions

Material risks

  • Cyclicality: a large share of demand is industrial capex-driven; a downturn in reshoring, semiconductor or aerospace investment would slow instrument and inspection-equipment orders and pressure organic growth.
  • Acquisition and goodwill risk: AMETEK is a serial acquirer (FARO ~$920M in 2025) whose model depends on accretive integration; overpayment, integration missteps or a demand shortfall could lead to intangible/goodwill impairment.
  • Disclosure opacity: metrology/inspection revenue is not broken out below the EIG segment, making it hard to verify the pace of theme-specific growth or to isolate FARO's contribution.
  • FX and geographic risk: sales span North America, Europe, Asia and South America, so a stronger US dollar and regional slowdowns weigh on translated results.
  • Valuation risk: AMETEK typically trades at a premium multiple; without licensed market data this cannot be quantified here, but multiple compression is a risk to total return.

Thesis-break conditions

  • EIG organic (core) sales decline for two or more consecutive quarters, indicating the structural-growth and inspection demand thesis is failing.
  • Adjusted operating margin falls sustainably below ~24% (from the FY2025 26.2%), signaling lost pricing power or integration dilution.
  • Free-cash-flow conversion drops materially below ~100% of net income, or a goodwill impairment tied to FARO/Ultra Precision Technologies is recognized, indicating the M&A compounding engine has stalled.
Investability conclusion

Where the evidence lands

On the public evidence, AMETEK screens as a durable, cash-generative compounder with disclosed, product-line-level exposure to industrial inspection and metrology that was deepened by the July 2025 FARO acquisition, supported by record FY2025 sales ($7.4B), ~26% adjusted operating margins, ~$1.67B free cash flow and low leverage. The principal analytical constraints are that metrology/inspection revenue is not separately disclosed (so theme sizing is not possible from segment data) and that valuation cannot be evaluated without licensed market data. This is an evidence-based assessment of exposure and quality, not a recommendation or trading advice.

Next diligence

  1. Obtain the FY2025 Form 10-K segment and MD&A footnotes to attempt to size the Ultra Precision Technologies / metrology-inspection franchise within EIG and to capture the reported year-end backlog figure.
  2. Track FARO integration progress, organic-growth and margin disclosures in AMETEK's 2026 quarterly filings and earnings calls to test the accretion thesis.
  3. Secure licensed market data (share price, shares outstanding, net debt) to compute EV/EBITDA and free-cash-flow yield, which are currently unavailable.
  4. Break down EIG demand by end market (semiconductor, aerospace, medical, automation) to gauge concentration and cyclicality of the inspection exposure.
  5. Confirm total/net debt and net-debt-to-EBITDA from the balance sheet to complete the leverage picture (packet values were unavailable).
Source ledger

Identity and evidence sources

Identity was verified against official issuer, filing, exchange, or regulator sources where available.

  1. AMETEK INC/ FY2025 Form 10-K (source of packet-reported metrics)U.S. Securities and Exchange Commission (EDGAR) · primary · published 2026-02-17 · accessed 2026-07-22
  2. AMETEK Announces Record Fourth Quarter and Full Year ResultsAMETEK, Inc. (via PR Newswire) · primary · published 2026-02-03 · accessed 2026-07-22
  3. AMETEK About Us / corporate profile (HQ Berwyn, PA; NYSE:AME)AMETEK, Inc. · primary · published n/a · accessed 2026-07-22
  4. AMETEK Expands Ultra Precision Technologies Division With Completion of FARO AcquisitionMetrology.News · secondary · published 2025-07-22 · accessed 2026-07-22
  5. Precision semiconductor technology for the modern world (names Taylor Hobson, Gatan, CAMECA, SPECTRO/Nu Instruments)AMETEK, Inc. · primary · published 2025-04 · accessed 2026-07-22